World's Best Scientists 2026 revealed!
Peter A. Noseworthy

Peter A. Noseworthy

D-Index & Metrics

Medicine

D-Index
80
Citations
29383
World Ranking
16958
National Ranking
8504

Overview

Peter A. Noseworthy is affiliated with the Mayo Clinic in the United States and has a substantial record of research primarily in Medicine, with a focus on Cardiology and Cardiovascular Medicine. Their work encompasses several subfields, including Surgery, Radiology, Nuclear Medicine and Imaging, Epidemiology, and Economics and Econometrics.

Their research attention centers around topics such as:

  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • ECG Monitoring and Analysis
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics

Recent papers authored or coauthored by Peter A. Noseworthy include:

  • Artificial intelligence-enhanced electrocardiography in cardiovascular disease management, 2021, Nature Reviews Cardiology
  • 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation, 2023, Journal of the American College of Cardiology
  • Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association, 2020, Circulation
  • Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure, 2021, Circulation
  • Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19), 2020, Mayo Clinic Proceedings

Frequent coauthors include:

  • Paul A. Friedman
  • Zachi I. Attia
  • Francisco López-Jiménez
  • Konstantinos C. Siontis
  • Anthony H. Kashou

Peter A. Noseworthy has published extensively in several leading venues, which include:

  • Circulation
  • Journal of the American College of Cardiology
  • European Heart Journal
  • Mayo Clinic Proceedings
  • Heart Rhythm

The scientist's research production comprises over nine hundred publications primarily in Medicine, with the majority focusing on Cardiology and Cardiovascular Medicine. Their studies contribute notably to understanding atrial fibrillation and cardiac arrhythmias, emphasizing clinical management, diagnostic techniques, and therapeutic outcomes.

Best Publications

  • Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial

    Douglas L. Packer;Daniel B. Mark;Richard A. Robb;Kristi H. Monahan

  • An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction.

    Zachi I Attia;Peter A Noseworthy;Francisco Lopez-Jimenez;Samuel J Asirvatham

  • Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogram

    Zachi I. Attia;Suraj Kapa;Francisco Lopez-Jimenez;Paul M. McKie

  • Common variants at ten loci influence QT interval duration in the QTGEN Study.

    Christopher Newton-Cheh;Christopher Newton-Cheh;Mark Eijgelsheim;Kenneth M Rice;Paul I W de Bakker;Paul I W de Bakker

  • Artificial intelligence-enhanced electrocardiography in cardiovascular disease management

    Konstantinos C. Siontis;Peter A. Noseworthy;Zachi I. Attia;Paul A. Friedman

  • Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.

    Xiaoxi Yao;Nilay D. Shah;Lindsey R. Sangaralingham;Bernard J. Gersh

  • Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.

    Xiaoxi Yao;Neena S. Abraham;Lindsey R. Sangaralingham;M. Fernanda Bellolio

  • Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19).

    John R. Giudicessi;Peter A. Noseworthy;Paul A. Friedman;Michael J. Ackerman

  • Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States

    Konstantinos C. Siontis;Konstantinos C. Siontis;Xiaosong Zhang;Ashley Eckard;Nicole Bhave

  • Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

    Xiaoxi Yao;Neena S. Abraham;G. Caleb Alexander;William Crown

  • QTc prolongation, torsades de pointes, and psychotropic medications.

    Scott R. Beach;Christopher M. Celano;Peter A. Noseworthy;James L. Januzzi

  • Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association.

    Mina K. Chung;Lee L. Eckhardt;Lin Y. Chen;Haitham M. Ahmed

  • Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.

    Douglas L. Packer;Jonathan P. Piccini;Kristi H. Monahan;Hussein R. Al-Khalidi

  • Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.

    Lin Y. Chen;Mina K. Chung;Larry A. Allen;Michael Ezekowitz

  • Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization

    Dan E. Arking;Sara L. Pulit;Sara L. Pulit;Sara L. Pulit;Lia Crotti;Pim Van Der Harst

  • Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association.

    Dhanunjaya R Lakkireddy;Mina K Chung;Rakesh Gopinathannair;Kristen K Patton

  • Age and Sex Estimation Using Artificial Intelligence From Standard 12-Lead ECGs.

    Zachi I. Attia;Paul A. Friedman;Peter A. Noseworthy;Francisco Lopez-Jimenez

  • Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation.

    Xiaoxi Yao;Navdeep Tangri;Bernard J. Gersh;Lindsey R. Sangaralingham

  • Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation

    Peter Noseworthy;Xiaoxi Yao;Neena Susan Abraham;Neena Susan Abraham;Lindsey R. Sangaralingham

  • Development and Validation of a Deep-Learning Model to Screen for Hyperkalemia From the Electrocardiogram.

    Conner D. Galloway;Alexander V. Valys;Jacqueline B. Shreibati;Daniel L. Treiman

Frequent Co-Authors

Paul A. Friedman
Paul A. Friedman Mayo Clinic
Bernard J. Gersh
Bernard J. Gersh Mayo Clinic
Christopher Newton-Cheh
Christopher Newton-Cheh Harvard University
Rickey E. Carter
Rickey E. Carter Mayo Clinic
Markus Perola
Markus Perola Finnish Institute for Health and Welfare
David O. Hodge
David O. Hodge Mayo Clinic
Jonathan P. Piccini
Jonathan P. Piccini Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in expanding your healthcare career options beyond a traditional MD degree? The healthcare field offers a variety of online degrees designed for professionals seeking flexibility, advancement, or a specialized focus.

For those drawn to leadership and management within hospitals and healthcare organizations, pursuing a healthcare administration online degree is a strong choice. If you are already a registered nurse, consider advancing your skills with adn to fnp bridge programs, which provide a streamlined path towards becoming a Family Nurse Practitioner.

Individuals passionate about public health and wellness may opt for an online bs in nutrition, enabling careers in dietetics, health education, or research. For those aiming for executive roles in healthcare, consider enrolling in one of the top cahme-accredited mha programs to gain prestigious credentials in healthcare administration.

These diverse online degree options open doors to clinical, administrative, and leadership positions—catering to a variety of professional goals within the rapidly evolving healthcare sector.

Best Scientists Citing Peter A. Noseworthy

Trending Scientists

Recently Published Articles